Saikosaponins: A potential treatment option for systemic lupus erythematosus

Irish Journal of Medical Science

Volumn 180, Issue 1, 2011, Pages 259-261

  Wu, G C ^a   Wu, H ^a   Fan, L Y ^a   Pan, H F ^b  

^a First People's Hospital   (China)

^b ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

Saikosaponins; Systemic lupus erythematosus; Treatment

Indexed keywords

CD69 ANTIGEN; CD71 ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 2; SAIKOSAPONIN A; SAIKOSAPONIN D; TRANSCRIPTION FACTOR NFAT; TRANSFORMING GROWTH FACTOR BETA1;

ANTIBACTERIAL ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTIVIRAL ACTIVITY; ARTICLE; BUPLEURUM FALCATUM; CD8+ T LYMPHOCYTE; DRUG EFFICACY; IMMUNOREGULATION; MACROPHAGE; MEDICINAL PLANT; NONHUMAN; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE ACTIVATION;

ANIMALS; AUTOIMMUNE DISEASES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LUPUS VASCULITIS, CENTRAL NERVOUS SYSTEM; OLEANOLIC ACID; SAPONINS;

EID: 79954444349     PISSN: 00211265     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11845-010-0646-4     Document Type: Article

References (24)

1. Agrawal N, Chiang LK, Rifkin IR (2006) Lupus nephritis. Semin Nephrol 26:95-104 (Pubitemid 43363384)
2. Boumpas DT, Sidiropoulos P, Bertsias G (2005) Optimum therapeutic approaches for lupus nephritis: what therapy and for whom? Nat Clin Pract Rheumatol 1:22-30
3. Ahmed MH, Osman MM (2007) Why does chloroquine impair renal function? chloroquine may modulate the renal tubular response to vasopressin either directly by inhibiting cyclic AMP generation, or indirectly via nitric oxide. Med Hypotheses 68:140-143 (Pubitemid 44767611)
4. Hanvesakul R, Kubal C, Jham S et al (2008) Increased incidence of infections following the late introduction of mycophenolate mofetil in renal transplant recipients. Nephrol Dial Transplant 23:4049-4053
5. Ernst E (2005) The efficacy of herbal medicine-an overview. Fundam Clin Pharmacol 19:405-409
6. Pan HF, Fang XH, Li WX et al (2008) Radix Astragali: a promising new treatment option for systemic lupus erythematosus. Med Hypotheses 71:311-312
7. Wang YL, He SX, Luo JY (2006) Progress in research on antitumor activity of saikosaponin and its mechanism. Zhong Xi Yi Jie He Xue Bao 4:98-100 [In Chinese]
8. Bermejo Benito P, Abad Martínez MJ, Silván Sen AM et al (1998) In vivo and in vitro anti-inflammatory activity of saikosaponins. Life Sci 63:1147-1156 (Pubitemid 29369120)
9. Recio MC, Just MJ, Giner RM et al (1995) Anti-inflammatory activity of saikosaponins from Heteromorpha trifoliate. J Nat Prod 58:140-144
10. Hiai S, Yokoyama H, Nagasawa T, Oura H (1981) Stimulation of the pituitary-adrenocortical axis by saikosaponin of Bupleuri radix. Chem Pharmacol Bull 29:495-499 (Pubitemid 11121647)
11. Yamaguchi N, Kohno H, Tawara M et al (1985) Effect of saikosaponin derivatives upon the immune response against T-dependent and T-independent antigens in mice. Int J Immunopharmacol 7:827-832 (Pubitemid 16213249)
12. Ushio Y, Abe H (1991) Effects of saikosaponin-d on the functions and morphology of macrophages. Int J Immunopharmacol 13:493-499
13. Ushio Y, Abe H (1991) The effects of saikosaponin-d on yeast phagocytosis and degradation in peritoneal macrophages: related increase in Fc receptor expression and altered cytoplasmic organization. Jpn J Pharmacol 56:167-175
14. Chang WC, Hsu FL (1991) Inhibition of platelet activation and endothelial cell injury by flavan-3-ol and saikosaponin compounds, Prostaglandins Leukot Essent Fatty Acids 44:51-56
15. Motoo Y, Sawabu N (1994) Antitumor effects of saikosaponins, baicalin and baicalein on human hepatoma cell lines. Cancer Lett 86:91-95 (Pubitemid 24318987)
16. Zong Z, Fujikawa-Yamamoto K, Tanino M et al (1996) Saikosaponin b2-induced apoptosis of cultured B16 melanoma cell line through down-regulation of PKC activity. Biochem Biophys Res Commun 219:480-485
17. Zong Z, Fujikawa-Yamamoto K, Ota T et al (1998) Saikosaponin b2 induces differentiation without growth inhibition in cultured B16 melanoma cells. Cell Struct Funct 23:265-272 (Pubitemid 29015718)
18. Shimizu I (2000) Sho-saiko-to: Japanese herbal medicine for protection against hepatic fibrosis and carcinoma. J Gastroenterol Hepatol 15 (Suppl): D84-D90 (Pubitemid 30190730)
19. Leung CY, Liu L, Wong RN et al (2005) Saikosaponin-d inhibits T cell activation through the modulation of PKCtheta, JNK, and NF-kappaB transcription factor. Biochem Biophys Res Commun 338:1920-1927 (Pubitemid 41643109)
20. Li P, Gong Y, Zu N et al (2005) Therapeutic mechanism of Saikosaponin-d in anti-Thy1 mAb 1-22-3-induced rat model of glomerulonephritis. Nephron Exp Nephrol 101: e111-e118
21. Xu AP, Wang Z, Lv J et al (2007) Therapeutic effects of Saikosaponin-d on lupus nephritis in NZBWF1 mice. J Fourth Mil Med Univ 28:2148-2151 [in Chinese]
22. Xu AP, Wang Z, Yang P et al (2007) Effects of Saikosaponin-d on improving the damage of renal tissue in NZBWF1 mice. Anat Res 29:344-348 [in Chinese]
23. Wong VK, Zhou H, Cheung SS et al (2009) Mechanistic study of saikosaponin-d (Ssd) on suppression of murine T lymphocyte activation. J Cell Biochem 107:303-315
24. Sun Y, Cai TT, Zhou XB, Xu Q (2009) Saikosaponin a inhibits the proliferation and activation of T cells through cell cycle arrest and induction of apoptosis. Int Immunopharmacol 9:978-983